Hemorrhoids Treatment Market Report Scope & Overview:
The hemorrhoids treatment market size was valued at USD 1.13 billion in 2024 and is expected to reach USD 1.82 billion by 2032, growing at a CAGR of 6.15% over 2025-2032.
The global burden of anorectal disorders is continuously increasing due to the growing incidence of obesity, sedentary lifestyle, and constipation is responsible for the ongoing penetration of the hemorrhoids treatment market share. The growing geriatric population, particularly in the U.S., where hemorrhoids mostly affect older adults, is driving market demand. In addition, increasing knowledge and easy access to over-the-counter (OTC) drugs, and technological advancements in non-surgical treatments such as infrared coagulation and rubber band ligation, are anticipated to propagate the growth of the global hemorrhoids therapy market over the forecast period.
Church & Dwight strengthened its position in the hemorrhoids treatment market in April 2024 with the launch of a new hemorrhoid cream that provides dual-action pain relief and anti-inflammatory properties.
The regulatory approvals for newer topical agents and improved surgical devices drive the hemorrhoids treatment market growth. One instance is Sebela Pharmaceuticals, which has opened new indications for rectal therapies. In addition, increasing focus of companies such as Bayer and GlaxoSmithKline on R&D investments for anti-inflammatory and pain-relief formulations is leading to further innovations in the hemorrhoids treatment landscape.
Rapid e-commerce infrastructure growth is expected to boost drug availability in the market. Augmented healthcare spending in the U.S. encourages treatment penetration, with supportive reimbursement schemes for hemorrhoids treatment, complemented by authoritative verification of safety and effectiveness by regulatory authorities. Preference for outpatients is climbing, and so too are market dynamics leading the conversation towards less invasive practices. Based on the hemorrhoids treatment market trend, hemorrhoids treatment market analysis, oral and topical solutions are expected to hold a significant share of the market due to their less expensive cost and ease of usage (Oral analgesics like Acetaminophen & Topical (analgesics or NSAID) continue to impact a huge patient population for providing symptomatic relief.
Boston Scientific Corporation announced in January 2024 clinical trials of a minimally invasive device designed for the elimination of internal hemorrhoids, reflecting foundational hemorrhoids treatment market trends leading toward procedural innovation and better patient compliance.
Market Dynamics:
Drivers:
-
Increasing Treatment Demand, Advancing Technologies, and Rising Healthcare Investments Propel Market Expansion
The hemorrhoids treatment market is majorly driven by the growing demand on account of the increasing incidence of constipation, obesity, unhealthy eating habits, and sedentary lifestyles. This generates ongoing product demand as over 75% of the population in developed nations will experience hemorrhoids at some point in their life. Treatment options like non-invasive devices, bioactive creams, and suppository delivery system enhancements have increased the number of patients who can be treated effectively while increasing comfort and driving adoption. Novel formulations that are fast-acting with minimal side effects have piqued the interest of companies like Taro Pharmaceuticals and Teva. Additionally, substantial R&D spend is being done to introduce corticosteroid-sparing drugs and natural herbal combinations, suiting the rising trend of milder prescriptions.
In 2023, gastrointestinal therapeutics were a leading driver of the 12% overall increase in pharma R&D pipelines, according to Pharma Intelligence. The development of such technologies is influenced by the regulatory approvals, the latest being FDA approval for radio frequency-based radiosurgery systems provides a safe and effective outpatient option in hemorrhoid treatment. Besides, hospitals and ambulatory centers are observed to be buying more value-proctology devices, which in turn boosts the sales in the procedural volume growth. These factors, along with improved insurance coverage in many countries, are propelling the demand for hemorrhoids treatment and widening patient access across the Rx prescription and over-the-counter OTC segment.
Restraints:
-
Social Stigma, Limited Awareness, and an Inconsistent Regulatory Landscape Hinder Market Growth
Even with this robust demand, the hemorrhoid treatment market is inhibited by key growth restraints such as low disease awareness, a considerable lag in diagnosis, and an enduring social stigma regarding anorectal diseases. Embarrassment will lead to many putting off visiting a doctor, while others will simply ignore symptoms because they believe it is 'better the devil you know'. Consequently, the early treatment window, the one in which non-surgical treatments tend to be most effective, is best of easily escaped.
Additionally, a lack of standard regulations and over-the-counter (OTC) product classification in different countries can impede the market to a certain extent. Such is the case with some herbal or topical agents that have not been clinically validated or do not meet rigorous regulatory standards for efficacy, making them difficult to trust and adopt by physicians. Supply issues in 2022 were blamed for shortages of the crucial corticosteroid-based hemorrhoid treatments, with key active pharmaceutical ingredients (APIs) coming from manufacturing plants that have been hit by interruptions to manufacturing in Asia. Moreover, out-of-pocket expenditure is higher due to reimbursement gaps for new treatments such as laser therapy or RF ablation, making these treatments less than optimal. Hemorrhoids, which are not a life-threatening disease compared to chronic diseases, have consequently received low-level funding over the years in terms of Public Health Programmes.
Segmentation Analysis:
By Treatment Type
Pharmacological treatments were the most frequently prescribed hemorrhoids treatment in 2024, as a result of being over-the-counter commercial features for creams, suppositories, and oral medication to manage Phase I-Grade II hemorrhoids. A lot of this prevalence was driven by their affordability, ability to self-administer, and mass-dispensability over-the-counter.
Most notable are non-surgical procedures, which report the fastest growth as growing numbers of patients require treatment for conditions such as rubber band ligation, infrared coagulation, and sclerotherapy that all offer specific benefits, recovery time, and complication rates in an ambulatory setting.
By Route of Administration
Topical treatments accounted for the maximum share in 2024, at 46%, as patients opt for quick relief treatments including creams, ointments, and gels, especially concerning external hemorrhoids. Local application, along with symptom targeting, leads to its major domination.
The rectal route will be the fastest growing and is driven by increasing clinician preference for higher efficacy suppositories and rectal foams that provide improved relief from internal hemorrhoids along with enhanced absorption.
By Type
Internal hemorrhoids led the market within 2024, of the total cases treated, there were about 58% internal hemorrhoids because they happen to be more common and cause reasonable bleeding or discomfort that usually need medical or procedural intervention.
The external hemorrhoids segment is the largest and fastest-growing, powered by self-treatment with OTC products and increasing awareness of hygiene and symptom management.
By Distribution Channel
Retail pharmacies & drug stores had the largest portion in 2024, accounting for 48% due to higher consumer convenience of OTC drugs and pharmacist-recommended remedies. This, coupled with the physical presence and availability of newsagents nearby, has made it the most natural go-to channel.
Online pharmacies are the fastest-growing distribution channel supported by growing e-commerce penetration, discrete purchasing options, and doorstep delivery of hemorrhoid medicines and wellness products.
Regional Analysis:
In 2024, North America led the global hemorrhoids treatment market because of its developed healthcare infrastructure, large number of aware people, and major pharmaceutical companies & medical devices in this region.
The U.S. hemorrhoids treatment market size was valued at USD 0.34 billion in 2024 and is expected to reach USD 0.52 billion by 2032, growing at a CAGR of 5.33% over 2025-2032. In the U.S., harrowing level of piles nationwide, attacks nearly 1 in 20 Americans annually, and results in an estimated 10 million doctor consultations for hemorrhoid-related troubles. High demand for OTC drugs and easy availability of less invasive surgical procedures further deepen the dominance. Despite its smaller population, Canada is also experiencing growth due in part to the expansion of preventive care and retail pharmacy.
The Asia Pacific is expected to be the fastest-growing region in this market due to the rapidly increasing number of patients, high. Urbanization and a large pool of patients with low. Impossible access to healthcare. Owing to the presence of a large aging population and rising consumption of OTC drugs, China is the market leader. Hemorrhoids afflict as many as 12–15% of adults in urban areas. With rising awareness about anorectal health and cost-effective generic products flooding the space, the Indian market is making significant strides. Growing investments in Japan and South Korea for hospital infrastructure and e-pharmacy platforms fostered international expansion.
Key Players:
Leading hemorrhoids treatment companies include Lupin, Cipla, AMATO Pharmaceutical Products, Church & Dwight Co., Haleon, Sebela Pharmaceuticals, Bayer, Sanofi, Abbott, Sun Pharmaceutical Industries, AstraZeneca, Boehringer Ingelheim, Boston Scientific Corporation, CONMED Corporation, Cook Medical, GlaxoSmithKline, Olympus Corporation, Pfizer, Takeda Pharmaceutical Company, and Glenmark Pharmaceuticals.
Recent Developments:
In April 2024, Innovus Pharmaceuticals launched a new over-the-counter hemorrhoid relief cream formulated with lidocaine and natural botanicals, targeting the growing demand for topical and non-invasive solutions. This product launch strengthens their consumer health portfolio in the gastrointestinal segment.
In February 2024, Medtronic announced the expansion of its minimally invasive surgical hemorrhoid treatment device across select Asia Pacific markets. The initiative aims to improve patient outcomes and cater to the rising incidence of severe hemorrhoidal disease in the region.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 1.13 billion |
| Market Size by 2032 | USD 1.82 billion |
| CAGR | CAGR of 6.15% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Treatment Type [Pharmacological Treatments [Laxatives, NSAIDs, Corticosteroids, Local Anesthetics, Herbals, Others (e.g., flavonoids, vasoconstrictors, astringents)], Non-Surgical Procedures [Rubber Band Ligation, Sclerotherapy, Infrared Coagulation, Cryotherapy], Surgical Procedures [Hemorrhoidectomy, Stapled Hemorrhoidopexy]] • By Route of Administration [Oral, Topical, Rectal] • By Type [Internal Hemorrhoids, External Hemorrhoids] • By Distribution Channel [Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies] |
| Regional Analysis/Coverage | North America (U.S., Canada), Europe (Germany, France, UK, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, Egypt, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America) |
| Company Profiles | Lupin, Cipla, AMATO Pharmaceutical Products, Church & Dwight Co., Haleon, Sebela Pharmaceuticals, Bayer, Sanofi, Abbott, Sun Pharmaceutical Industries, AstraZeneca, Boehringer Ingelheim, Boston Scientific Corporation, CONMED Corporation, Cook Medical, GlaxoSmithKline, Olympus Corporation, Pfizer, Takeda Pharmaceutical Company, and Glenmark Pharmaceuticals. |
Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Treatment Type
2.3.2 Market Size By Route of Administration
2.3.3 Market Size By Type
2.3.4 Market Size By Distribution Channel
2.4 Market Share & BPS Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Life Cycle Assessment
3.5 Parent Market Overview
3.6 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Reimbursement & Coverage Trends
4.1.1 Country-wise Payer Coverage Analysis
4.1.2 Cost-Effectiveness and HTA Trends
4.2 R&D Investment and Funding Trends
4.2.1 Venture Capital and IPO Activity (2020–2024)
4.2.2 Public-Private and Regulatory-Backed Initiatives
4.3 Technology Integration Trends
4.3.1 AI and Predictive Analytics
4.3.2 Smart Devices and Treatment Innovations
4.4 Clinical Trials and Pipeline Progression Metrics
4.4.1 Hemorrhoid Treatment Clinical Trials by Type
4.4.2 Trial Enrollment and Patient Access Trends
4.5 Diagnostic and Treatment Penetration Rates
4.5.1 Adoption of Non-Surgical Treatments
4.5.2 Topical and Oral Treatment Utilization
5. Hemorrhoids Treatment Market Segmental Analysis & Forecast, By Treatment Type, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Pharmacological Treatments
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.2.3 Laxatives
5.2.3.1 Key Trends
5.2.3.2 Market Size & Forecast, 2021 – 2032
5.2.4 NSAIDs
5.2.4.1 Key Trends
5.2.4.2 Market Size & Forecast, 2021 – 2032
5.2.5 Corticosteroids
5.2.5.1 Key Trends
5.2.5.2 Market Size & Forecast, 2021 – 2032
5.2.6 Local Anesthetics
5.2.6.1 Key Trends
5.2.6.2 Market Size & Forecast, 2021 – 2032
5.2.7 Herbals
5.2.7.1 Key Trends
5.2.7.2 Market Size & Forecast, 2021 – 2032
5.2.8 Others (e.g., flavonoids, vasoconstrictors, astringents)
5.2.8.1 Key Trends
5.2.8.2 Market Size & Forecast, 2021 – 2032
5.3 Non-Surgical Procedures
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.3.3 Rubber Band Ligation
5.3.3.1 Key Trends
5.3.3.2 Market Size & Forecast, 2021 – 2032
5.3.4 Sclerotherapy
5.3.4.1 Key Trends
5.3.4.2 Market Size & Forecast, 2021 – 2032
5.3.5 Sclerotherapy
5.3.5.1 Key Trends
5.3.5.2 Market Size & Forecast, 2021 – 2032
5.3.6 Infrared Coagulation
5.3.6.1 Key Trends
5.3.6.2 Market Size & Forecast, 2021 – 2032
5.3.7 Cryotherapy
5.3.7.1 Key Trends
5.3.7.2 Market Size & Forecast, 2021 – 2032
5.4 Surgical Procedures
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
5.4.3 Hemorrhoidectomy
5.4.3.1 Key Trends
5.4.3.2 Market Size & Forecast, 2021 – 2032
5.4.4 Stapled Hemorrhoidopexy
5.4.4.1 Key Trends
5.4.4.2 Market Size & Forecast, 2021 – 2032
6. Hemorrhoids Treatment Market Segmental Analysis & Forecast, By Route of Administration, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Oral
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Topical
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Rectal
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
7. Hemorrhoids Treatment Market Segmental Analysis & Forecast, By Type, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Internal Hemorrhoids
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 External Hemorrhoids
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
8. Hemorrhoids Treatment Market Segmental Analysis & Forecast, By Distribution Channel, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Hospital Pharmacies
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Retail Pharmacies & Drug Stores
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Online Pharmacies
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
9. Hemorrhoids Treatment Market Segmental Analysis & Forecast By Region, 2021 – 2032, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.2.3 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.2.4 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.2.5 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.2.6 Hemorrhoids Treatment Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.2.6.1.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.2.6.1.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.2.6.1.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.2.6.2.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.2.6.2.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.2.6.2.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.3 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.4 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.3.5 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6 Hemorrhoids Treatment Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.1.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.1.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.3.6.1.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.2.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.2.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.3.6.2.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.3.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.3.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.3.6.3.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.4.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.4.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.3.6.4.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.5.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.5.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.3.6.5.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.6.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.6.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.3.6.6.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.7.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.7.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.3.6.7.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.8.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.8.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.3.6.8.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.3 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.4 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.4.5 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6 Hemorrhoids Treatment Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.1.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.1.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.4.6.1.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.2.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.2.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.4.6.2.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.3.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.3.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.4.6.3.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.4.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.4.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.4.6.4.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.5.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.5.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.4.6.5.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.6.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.6.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.4.6.6.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.7.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.7.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.4.6.7.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.5.3 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.5.4 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.5.5 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.5.6 Hemorrhoids Treatment Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.5.6.1.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.5.6.1.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.5.6.1.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.5.6.2.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.5.6.2.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.5.6.2.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.5.6.3.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.5.6.3.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.5.6.3.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.5.6.4.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.5.6.4.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.5.6.4.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.5.6.5.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.5.6.5.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.5.6.5.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.3 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.4 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.6.5 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6.6 Hemorrhoids Treatment Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.6.1.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.6.1.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.6.6.1.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.6.2.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.6.2.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.6.6.2.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.6.3.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.6.3.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.6.6.3.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.6.4.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.6.4.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.6.6.4.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.6.5.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.6.5.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.6.6.5.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Hemorrhoids Treatment Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.6.6.2 Hemorrhoids Treatment Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.6.6.3 Hemorrhoids Treatment Market Size & Forecast, By Type, 2021 – 2032
9.6.6.6.4 Hemorrhoids Treatment Market Size & Forecast, By Distribution Channel, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number of Strategies Adopted by Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Lupin
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Cipla
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 AMATO Pharmaceutical Products
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Church & Dwight Co.
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Haleon
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Sebela Pharmaceuticals
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Bayer
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 Sanofi
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Abbott
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Sun Pharmaceutical Industries
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 AstraZeneca
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Boehringer Ingelheim
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Boston Scientific Corporation
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 CONMED Corporation
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Cook Medical
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 GlaxoSmithKline
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Olympus Corporation
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 Pfizer
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 Takeda Pharmaceutical Company
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Glenmark Pharmaceuticals
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Key Segments
By Treatment Type
- Pharmacological Treatments
- Laxatives
- NSAIDs
- Corticosteroids
- Local Anesthetics
- Herbals
- Others (e.g., flavonoids, vasoconstrictors, astringents)
- Non-Surgical Procedures
- Rubber Band Ligation
- Sclerotherapy
- Infrared Coagulation
- Cryotherapy
- Surgical Procedures
- Hemorrhoidectomy
- Stapled Hemorrhoidopexy
By Route of Administration
- Oral
- Topical
- Rectal
By Type
- Internal Hemorrhoids
- External Hemorrhoids
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- Egypt
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
Detailed analysis and profiling of additional market players
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
